12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

• OncoCyte (NASDAQ:OCX) stock increased by 57.5% to $0.31 during Thursday's regular session. Trading volume for this security as of 13:30 EST is 4.8 million, which is 1766.1% of its average full-day volume over the last 100 days. The company's market cap stands at $37.3 million.
• Corbus Pharmaceuticals (NASDAQ:CRBP) shares moved upwards by 38.48% to $4.03. Trading volume for this security as of 13:30 EST is 1.3 million, which is 1913.4% of its average full-day volume over the last 100 days. The company's market cap stands at $16.8 million.
• Baudax Bio (NASDAQ:BXRX) shares rose 37.59% to $1.83. Trading volume for Baudax Bio's stock is 5.8 million as of 13:30 EST. This is 365.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.7 million.
• Genelux (NASDAQ:GNLX) stock moved upwards by 36.42% to $25.79. Genelux's stock is trading at a volume of 151.4K shares as of 13:30 EST. This is 79.8% of its average full-day volume over the last 100 days. The company's market cap stands at $607.7 million.
• Lipella Pharmaceuticals (NASDAQ:LIPO) stock increased by 32.24% to $2.42. As of 13:30 EST, this security is trading at a volume of 21.4 million shares, making up 3888.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.9 million.
• ThermoGenesis Holdings (NASDAQ:THMO) shares moved upwards by 30.23% to $5.46. As of 13:30 EST, ThermoGenesis Holdings's stock is trading at a volume of 24.3 million, which is 4126.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.6 million.

Losers

• Esperion Therapeutics (NASDAQ:ESPR) stock declined by 47.7% to $2.08 during Thursday's regular session. The current volume of 47.4 million shares is 2287.0% of Esperion Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $159.3 million.
• Paratek Pharmaceuticals (NASDAQ:PRTK) shares declined by 29.06% to $1.35. Trading volume for Paratek Pharmaceuticals's stock is 2.3 million as of 13:30 EST. This is 979.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $75.2 million. As per the news, the Q4 earnings report came out today.
• Gossamer Bio (NASDAQ:GOSS) stock decreased by 18.19% to $1.08. As of 13:30 EST, this security is trading at a volume of 3.2 million shares, making up 85.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $102.0 million.
• Kezar Life Sciences (NASDAQ:KZR) stock declined by 16.92% to $3.83. As of 13:30 EST, Kezar Life Sciences's stock is trading at a volume of 1.0 million, which is 184.0% of its average full-day volume over the last 100 days. The company's market cap stands at $271.1 million. The company's, Q4 earnings came out 2 days ago.
• HeartBeam (NASDAQ:BEAT) shares decreased by 14.92% to $2.51. HeartBeam's stock is trading at a volume of 105.0K shares as of 13:30 EST. This is 182.4% of its average full-day volume over the last 100 days. The company's market cap stands at $20.1 million. As per the press release, Q4 earnings came out today.
• Eloxx Pharmaceuticals (NASDAQ:ELOX) shares fell 12.53% to $2.55. The market value of their outstanding shares is at $5.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.